SeaStar Medical (NASDAQ:ICUCW – Get Free Report) is anticipated to announce its results after the market closes on Wednesday, August 12th. Analysts expect SeaStar Medical to announce earnings of ($0.97) per share and revenue of $0.4860 million for the quarter.
SeaStar Medical Stock Performance
ICUCW opened at $0.02 on Tuesday. The stock’s fifty day moving average is $0.02 and its two-hundred day moving average is $0.02. SeaStar Medical has a 52 week low of $0.01 and a 52 week high of $0.07.
SeaStar Medical Company Profile
SeaStar Medical, Inc is a medical device company developing dynamic instrument systems that replicate human wrist motion to enhance dexterity in minimally invasive surgery. The company’s technology provides surgeons with “wristed” articulation capabilities via a mechanically actuated linkage, offering a low-profile and cost-effective alternative to traditional robotic platforms.
SeaStar’s signature instrument platform is designed to integrate with existing laparoscopic trocars, enabling a seamless transition for operating rooms accustomed to conventional laparoscopic equipment.
Recommended Stories
- Five stocks we like better than SeaStar Medical
- SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
- 3 Dividend Champion Utilities for a Market That Can’t Sit Still
- These 3 Most-Upgraded Stocks Have Almost Nothing to Do With AI
- First Solar’s Profit Engine Faces a New Policy Test in Washington
Receive News & Ratings for SeaStar Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaStar Medical and related companies with MarketBeat.com's FREE daily email newsletter.
